Standard BioTools Inc

NASDAQ: LAB
Share price (6/12/24): $2.33
Market cap (6/12/24): $862 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

10 Standard BioTools Inc Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

Prospectuses and Registrations Filter

Shelf registration – amended

Shelf registration

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Casdin Capital, LLC

Casdin Partners GP, LLC, Casdin Capital, LLC, Casdin Eli, Casdin Partners Master Fund, L.P., Casdin Private Growth Equity Fund, L.P., Casdin Private Growth Equity Fund GP, LLC, Casdin Private Growth Equity Fund II, L.P., Casdin Private Growth Equity Fund II GP, LLC, Casdin Partners FO1-MSV, LP

Casdin Partners GP, LLC, Casdin Capital, LLC, Casdin Eli, Casdin Partners Master Fund, L.P., Casdin Private Growth Equity Fund, L.P., Casdin Private Growth Equity Fund GP, LLC, Casdin Private Growth Equity Fund II, L.P., Casdin Private Growth Equity Fund II GP, LLC, Casdin Partners FO1-MSV, LP

Casdin Capital, LLC

News Filter

Reports First Quarter 2024 Financial Results

Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

Reports Fourth Quarter and Full Year 2023 Financial Results

Proxies Filter

Additional info about upcoming vote

Proxy in contested situation

Preliminary revised proxy

Preliminary proxy in contested situation

Additional info about upcoming vote

Other Filter

Conflict Minerals disclosure

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC